ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01151709
Recruitment Status : Completed
First Posted : June 28, 2010
Last Update Posted : March 7, 2012
Sponsor:
Collaborator:
Takeda
Information provided by (Responsible Party):
Leslie Harrold, University of Massachusetts, Worcester

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This is a questionnaire study aimed at learning about physicians' views on the treatment of Gout.

Condition or disease
Gout

Detailed Description:

We seek to assess the knowledge, beliefs and reported treatment practices of primary care physicians with regard to gout.

Specifically, we will:

  • Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations.
  • Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.
  • Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 838 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Assessment of Primary Care Providers' Knowledge and Beliefs Regarding Gout Management
Study Start Date : August 2010
Actual Primary Completion Date : February 2012
Actual Study Completion Date : February 2012

Resource links provided by the National Library of Medicine

Genetics Home Reference related topics: Gout
MedlinePlus related topics: Gout

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
physicians
primary care practitioners, both family practice and internal medicine physicians from a random sample of providers nationwide


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Assess the knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations. [ Time Frame: 3 months ]
    Assess physicians' knowledge and beliefs with regard to acute and chronic gout management based on published treatment recommendations by means of questionnaire.

  2. Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting. [ Time Frame: 3 months ]
    Characterize the individuals who have knowledge deficits in terms of age, specialty, number of patients seen with gout, and practice setting.

  3. Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout. [ Time Frame: 3 months ]
    Assess the reported treatment practices of primary care physicians for the acute and chronic management of gout.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care practitioners, both family practice and internal medicine physicians from a nationwide sample
Criteria

Inclusion Criteria:

  • practicing primary care practitioner, either in family medicine or internal medicine,
  • must be 18 years of age or older

Exclusion Criteria:

  • does not meet inclusion criteria
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01151709


Locations
United States, Massachusetts
UMass Medical School
Worcester, Massachusetts, United States, 01566
Sponsors and Collaborators
University of Massachusetts, Worcester
Takeda
Investigators
Principal Investigator: Leslie R Harrold, MD UMass Medical School
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Leslie Harrold, Associate Professor of Medicine (UMMS), University of Massachusetts, Worcester
ClinicalTrials.gov Identifier: NCT01151709     History of Changes
Other Study ID Numbers: 13808
First Posted: June 28, 2010    Key Record Dates
Last Update Posted: March 7, 2012
Last Verified: March 2012

Keywords provided by Leslie Harrold, University of Massachusetts, Worcester:
Gout
Chronic condition management
Gout management

Additional relevant MeSH terms:
Gout
Arthritis
Joint Diseases
Musculoskeletal Diseases
Crystal Arthropathies
 Rheumatic Diseases
Purine-Pyrimidine Metabolism, Inborn Errors
Metabolism, Inborn Errors
Genetic Diseases, Inborn
Metabolic Diseases